OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,145,000 | +3.2% | 275,984 | 0.0% | 0.01% | +20.0% |
Q2 2022 | $1,109,000 | -36.0% | 275,984 | -21.2% | 0.01% | -28.6% |
Q1 2022 | $1,734,000 | +695.4% | 350,288 | +2536.7% | 0.01% | +600.0% |
Q1 2021 | $218,000 | -21.6% | 13,285 | -0.9% | 0.00% | 0.0% |
Q4 2020 | $278,000 | – | 13,410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |